PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 42 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

30 May 2025

  1. (diff | hist) 02:26 Glossary of peptide terminology 4,744 +133 CommaCarys (talk | contribs) expand the comparison so all four subjects have the same rows [rollback]

29 May 2025

  1. (diff | hist) m b 22:50 Prior authorisation 3,517 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) m b 13:35 Bacterial endotoxin test 4,428 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) 07:27 Vial 20,273 +531 ITT_Imelda (talk | contribs) state that overlay gas is used and name it [rollback]
  4. (diff | hist) m 01:47 Lot traceability 4,777 +749 OpenLabelOtto (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]

28 May 2025

  1. (diff | hist) 21:02 Timeline of incretin therapeutics 3,992 +38 BaselineBex (talk | contribs) expand §Physiology [rollback]
  2. (diff | hist) 19:35 Prescribing information 4,364 +40 HarmReductionHen (talk | contribs) give the cost per unit of effect rather than only the cost [rollback]
  3. (diff | hist) m b 16:01 Personal importation policy 3,251 ±0 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  4. (diff | hist) m 14:21 Xi'an Mokemei Biotechnology 5,787 +536 BPC_Bramwell (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  5. (diff | hist) 09:18 GL Biochem (Shanghai) 14,316 ±0 ForgeryFinder (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  6. (diff | hist) m 05:54 Bacteriostatic water 4,541 ±0 MissedDoseMik (talk | contribs) de-duplicate a repeated sentence [rollback]

27 May 2025

  1. (diff | hist) 10:58 Customs seizure 3,644 ±0 LabelLibby (talk | contribs) add the patent-expiry statement, attributed and dated [rollback]
  2. (diff | hist) m b 09:50 Peptide stability table 4,891 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 09:22 FLOW trial 4,414 +933 OpenLabelOtto (talk | contribs) fix indentation in the source [rollback]
  4. (diff | hist) 09:05 WuXi TIDES 11,615 +271 BatchNumberBede (talk | contribs) add the transit window each regional warehouse serves [rollback]
  5. (diff | hist) m 08:20 Peptide 6,609 +899 ColdChainCleo (talk | contribs) add the collapse-temperature point, sourced [rollback]
  6. (diff | hist) m 07:11 Drug master file 3,342 ±0 PharmDrafts (talk | contribs) rm the speculation about future scheduling [rollback]
  7. (diff | hist) 04:32 Trifluoroacetate counterion 3,899 ±0 NPOV_Nadia (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]
  8. (diff | hist) m b 02:25 Grey market 3,461 +277 CategoryBot (talk | contribs) bot: sort category members [rollback]

26 May 2025

  1. (diff | hist) m 22:22 Orforglipron 4,505 ±0 ComparisonCato (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  2. (diff | hist) 19:48 Temperature excursion 9,285 +3,135 CrudePeptidePearl (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  3. (diff | hist) 17:16 Guangzhou JEEP Biotechnology 12,188 +799 ForgeryFinder (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  4. (diff | hist) 16:36 Trial data comparison 4,925 +570 MarginNoteMars (talk | contribs) state the diluent volume the default assumes [rollback]
  5. (diff | hist) m 13:34 Baseline laboratory panel 4,222 +680 SPPS_Sorrel (talk | contribs) fix indentation in the source [rollback]
  6. (diff | hist) 10:44 Sigma-Aldrich (Shanghai) Trading 6,773 +538 INN_Ingrid (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  7. (diff | hist) m 08:43 Beyond-use date 13,672 ±0 SyringeSybille (talk | contribs) add the shelf life after first puncture, attributed [rollback]
  8. (diff | hist) 05:27 Active pharmaceutical ingredient 3,755 ±0 HOMA_Hettie (talk | contribs) add category for drug regulation [rollback]
  9. (diff | hist) m 02:52 Cost per milligram 3,292 +170 AnalyticalAnnie (talk | contribs) expand §Other axes that a price hides [rollback]
  10. (diff | hist) 00:39 Amino acid analysis 4,038 ±0 KarlFischerKit (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]

25 May 2025

  1. (diff | hist) m b 23:20 Flourishglobal Peptide Biotech 6,507 +347 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  2. (diff | hist) m 19:52 ChinaPeptides 9,312 +379 PatientPanelPru (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  3. (diff | hist) m b 18:35 CagriSema 4,167 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 14:39 Zhuhai Kerui Biotechnology 2,479 +738 KarlFischerKit (talk | contribs) de-duplicate a repeated sentence [rollback]
  5. (diff | hist) 12:39 Sarcopenia 3,762 +49 Chromatokid (talk | contribs) give the coefficient of variation with the level it was measured at [rollback]
  6. (diff | hist) 12:09 Glucagon-like peptide-1 11,229 ±0 UnitAuditUwe (talk | contribs) name the enzyme responsible for the cleavage at the first mention [rollback]
  7. (diff | hist) 10:07 Albumin binding half-life extension 6,021 +1,149 AmylinAmos (talk | contribs) move the trial material out of §Physiology into the compound articles [rollback]
  8. (diff | hist) m 04:42 Patent expiry and biosimilars 3,580 ±0 FiveOhThreeB (talk | contribs) clarify that a business licence is not a manufacturing authorisation [rollback]
  9. (diff | hist) m b 04:09 Cagrilintide 3,213 ±0 CiteBot (talk | contribs) bot: expand DOI to full citation [rollback]
  10. (diff | hist) m 03:15 Reference standard 4,806 +652 ExternalLinksEli (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]

24 May 2025

  1. (diff | hist) m 16:32 Receptor bias 3,536 ±0 TSH_Tallulah (talk | contribs) move the trial material out of §Physiology into the compound articles [rollback]
  2. (diff | hist) 14:19 Loss on drying 4,381 +616 KarlFischerKit (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  3. (diff | hist) m 12:24 Residual solvent 4,161 +36 SigFigSindri (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  4. (diff | hist) 07:35 Chain of custody 4,102 +17 MolarMassMaeve (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  5. (diff | hist) 07:30 Karl Fischer titration 7,949 +649 PreregPriya (talk | contribs) expand §Interpretation on a certificate of analysis [rollback]
  6. (diff | hist) 00:40 Survodutide 4,510 ±0 TirzTaxonomist (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]

23 May 2025

  1. (diff | hist) 17:55 TRIUMPH trial programme 4,035 +21 CagriCass (talk | contribs) label the extension study as an extension study in the table [rollback]
  2. (diff | hist) 16:00 Fasting insulin 3,910 +694 CPeptidePaddy (talk | contribs) add the pre-analytical requirement: tube type and time to separation [rollback]
  3. (diff | hist) m b 14:19 Insulin syringe unit conversion 4,444 ±0 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) 11:55 Crude peptide 3,938 +22 ColdChainCleo (talk | contribs) the article confused primary and secondary drying; corrected [rollback]
  5. (diff | hist) m b 11:44 Regulatory status by jurisdiction 3,662 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  6. (diff | hist) 09:24 Peptide harm reduction 3,975 ±0 AnalyticalAnnie (talk | contribs) split §Pricing from §Coverage [rollback]
  7. (diff | hist) 06:37 GLP-1 receptor agonist 9,758 ±0 MolarMassMaeve (talk | contribs) label the animal data as animal data in the sentence, not only in the section heading [rollback]
  8. (diff | hist) m 06:03 Chinese Peptide Company 11,801 ±0 Retention_Time_Rae (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  9. (diff | hist) 05:01 SELECT trial 4,851 +645 SelectTrialSam (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]

22 May 2025

  1. (diff | hist) 19:29 Sterile water for injection 4,413 ±0 DrTitration (talk | contribs) expand §When it is used rather than a preserved diluent [rollback]
  2. (diff | hist) 14:12 Deamidation 4,219 ±0 MassSpecMarv (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  3. (diff | hist) m b 10:49 Lixisenatide 4,034 +819 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 10:48 Talk:Guangzhou JEEP Biotechnology 1,170 +184 GradientGus (talk | contribs) /* Method disclosure within one report set */ reply
  5. (diff | hist) m 09:09 Shanghai Wibson Biotechnology 7,557 ±0 IncretinIvo (talk | contribs) add the standing talk-page note link to the banner [rollback]
  6. (diff | hist) m 06:14 Research use only 6,711 +22 PriorAuthPaz (talk | contribs) fix indentation in the source [rollback]
  7. (diff | hist) m 05:36 Fmoc chemistry 4,430 ±0 FreightFenna (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  8. (diff | hist) m b 04:06 Oral semaglutide 3,542 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  9. (diff | hist) m b 03:40 Underfilling 3,863 +431 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  10. (diff | hist) 02:07 Body composition assessment 4,416 +32 FormularyFrida (talk | contribs) clarify that the units differ between the two cited papers [rollback]
  11. (diff | hist) 01:33 Blind sampling 7,309 +529 EndotoxinEd (talk | contribs) correct the description of the sampling procedure [rollback]
  12. (diff | hist) m 00:40 Hunan Aslsen Technology 10,064 ±0 AnalyticalAnnie (talk | contribs) expand §Reception [rollback]

21 May 2025

  1. (diff | hist) 21:08 Semaglutide 8,560 ±0 DiffWatchDov (talk | contribs) de-orphan [rollback]
  2. (diff | hist) 18:01 Liraglutide 5,268 ±0 SemaglutideSasha (talk | contribs) add the structural figure and caption it properly [rollback]
  3. (diff | hist) 17:03 Reverse-phase HPLC 5,116 ±0 HOMA_Hettie (talk | contribs) fix a dangling clause [rollback]
  4. (diff | hist) 15:54 Global access disparity 3,314 ±0 PreregPriya (talk | contribs) expand §Consequences and framing [rollback]
  5. (diff | hist) 14:17 Sigma-Aldrich (Shanghai) Trading 6,235 +2,296 BlankVialBo (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  6. (diff | hist) 10:56 Contract development and manufacturing organisation 4,216 ±0 CustomsClarke (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  7. (diff | hist) N 09:00 Zhuhai Kerui Biotechnology 1,741 +1,741 SecondarySrc_Seb (talk | contribs) create organisation article per PP:VN
  8. (diff | hist) 08:16 Talk:Guangzhou JEEP Biotechnology 959 +119 Retention_Time_Rae (talk | contribs) /* Method disclosure within one report set */ reply
  9. (diff | hist) 08:02 Glucose-dependent insulinotropic polypeptide 6,898 +187 ProglucagonPia (talk | contribs) expand §Therapeutic exploitation [rollback]
  10. (diff | hist) 00:11 Arcuate nucleus 4,363 +42 TechnicianTeal (talk | contribs) the half-life given was for the intact peptide; label it [rollback]

20 May 2025

  1. (diff | hist) 15:33 Adverse effects of GLP-1 receptor agonists 5,314 ±0 RetinopathyRex (talk | contribs) add the note that titration exists partly to manage these effects [rollback]
  2. (diff | hist) m 15:15 Retention time 3,336 +30 RotationRosalind (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  3. (diff | hist) 15:08 Intention-to-treat analysis 4,637 +815 FlowTrialFraser (talk | contribs) add the year of publication to each trial in the list [rollback]
  4. (diff | hist) 13:44 Talk:Guangzhou JEEP Biotechnology 748 +260 AnalyticalAnnie (talk | contribs) /* Method disclosure within one report set */ reply
  5. (diff | hist) 12:51 Placebo-adjusted effect 3,893 ±0 ParentCatPansy (talk | contribs) expand §How figures are misreported [rollback]
  6. (diff | hist) m 11:57 Reconstitution calculator 6,980 +751 CustomsClarke (talk | contribs) close an unbalanced quotation mark [rollback]
  7. (diff | hist) m b 09:51 Number needed to treat 3,631 ±0 ArchiveBot (talk | contribs) bot: expand PMID to full citation [rollback]
  8. (diff | hist) 09:29 Talk:Guangzhou JEEP Biotechnology 537 +297 GradientGus (talk | contribs) /* Method disclosure within one report set */ new section
  9. (diff | hist) m 03:22 Methionine oxidation 3,850 ±0 AnaesthesiaAoife (talk | contribs) add the repeatability figure with the number of injections [rollback]
  10. (diff | hist) 01:30 Counterfeit peptide 4,235 ±0 ChainCustodyChad (talk | contribs) expand §Substitution [rollback]
  11. (diff | hist) 01:07 Multi-dose vial 15,615 +646 FormularyFrida (talk | contribs) consistent en dashes in ranges [rollback]

19 May 2025

  1. (diff | hist) 20:05 Batch number 3,731 ±0 AnalyticalAnnie (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  2. (diff | hist) m 18:02 Vial filling and stoppering 4,012 ±0 SecondarySrc_Seb (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  3. (diff | hist) m 13:45 Insulin secretion 6,373 +404 TesamorelinTeg (talk | contribs) add the citation for the co-secretion finding [rollback]
  4. (diff | hist) m 13:42 Custom peptide synthesis 4,512 +735 DPP4_Dagmar (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  5. (diff | hist) 01:24 Dipeptidyl peptidase-4 6,022 ±0 DataTableDunja (talk | contribs) add the enteroendocrine cell type responsible for secretion [rollback]
  6. (diff | hist) m 00:13 Hubei Jianxiang Bioscience 5,320 +491 Chromatokid (talk | contribs) space between number and unit per PP:MOS [rollback]

18 May 2025

  1. (diff | hist) m 11:53 Proglucagon 5,743 ±0 HalfLifeHavel (talk | contribs) the half-life given was for the intact peptide; label it [rollback]
  2. (diff | hist) 10:21 Talk:Beyond-use date 1,307 +87 Ref_Desk_Ron (talk | contribs) /* Category 2 table: which revision, and should earlier revisions be shown? */ reply
  3. (diff | hist) m 08:58 Weight regain after discontinuation 4,048 +17 Areapercent_Ayo (talk | contribs) state that the frequency category follows the labelling convention [rollback]
  4. (diff | hist) m 08:19 Peptide supply chain 6,954 ±0 CounterfeitCato (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]

17 May 2025

  1. (diff | hist) 23:32 Test report forgery 4,203 ±0 PancreasPru (talk | contribs) fix hyphenation per PP:MOS [rollback]
  2. (diff | hist) 21:31 MOTS-c 3,596 +256 MOTSc_Mira (talk | contribs) clarify that the compound is sold as an acetate salt [rollback]
  3. (diff | hist) 20:18 Peptide aggregation 4,377 ±0 TFA_Counterion (talk | contribs) split §Principle from §Practical limitations [rollback]